Form 4 for STE Steris
Accepted 2022-06-17 00:00:00 ET · period of report 2022-06-15 · accession 0001209191-22-037903 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-17 | 2022-06-15 | STE | Zangerle John Adam | SVP, Gen Counsel, Sec | S - Sale | $205.31 | -2,659 | 27.9K | -9% | -$545.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-06-15 | S | D | 2,659 | $205.31 | 27,936 | D | — | — | (F1) This sale of 2,659 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on February 11, 2022. (F2) As of June 15, 2022, 8,987 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 202 on October 3, 2022; 834 on May 31, 2023; 752 on June 1, 2023; 846 on June 2, 2023; 819 on June 2, 2023; 202 on October 2, 2023; 846 on June 3, 2024; 752 on June 3, 2024; 819 on June 3, 2024; 202 on October 1, 2024; 819 on June 2, 2025; 846 on June 2, 2025; 202 on October 1, 2025 and 846 on June 2, 2026. |